Interpace Biosciences Inc IDXG
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- —
- Day Range
- —–—
- 52-Week Range
- —–—
- Bid/Ask
- — / —
- Shares Outstanding
- 5.90M
- Market Cap
- —
- Volume/Avg
- — / —
Key Statistics
- Price/Earnings (Normalized)
- 8.25
- Price/Sales
- 0.97
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Interpace Biosciences Inc provides esoteric molecular diagnostic testing and pathology services to aid physicians in evaluating cancer risk in patients with indeterminate biopsies and a perceived high risk of cancer based on clinical features. The company develops and commercializes genomic tests and related first-line assays that can personalize medicine and help improve patient diagnosis and management. Its clinical customers mainly consist of physicians, hospitals, cancer centers, commercial laboratories, pathology groups, and clinics. The various diagnostic tests offered by the company include ThyGeNEXT and ThyraMIRv2 for the detection of thyroid cancer.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Stock Style Box
- Small Value
- Total Number of Employees
- 102
- Website
- https://www.interpace.com
Valuation
|
Metric
|
IDXG
|
|---|---|
Price/Earnings (Normalized) | 8.25 |
Price/Book Value | 1.52 |
Price/Sales | 0.97 |
Price/Cash Flow | 7.62 |
Price/Earnings
IDXG
Financial Strength
|
Metric
|
IDXG
|
|---|---|
Quick Ratio | 1.82 |
Current Ratio | 2.22 |
Interest Coverage | 96.19 |
Quick Ratio
IDXG
Profitability
|
Metric
|
IDXG
|
|---|---|
Return on Assets (Normalized) | 99.26% |
Return on Equity (Normalized) | 186.42% |
Return on Invested Capital (Normalized) | 165.38% |
Return on Assets
IDXG
Diagnostics & Research Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Thermo Fisher Scientific Inc
TMO
| LOCK|##hP>Ygb | LOCK|yS | $241B | |||
| Danaher Corp
DHR
| LOCK|$ccP&<$ | LOCK|@WV | $149B | |||
| Agilent Technologies Inc
A
| LOCK|!<cJ!ZP? | LOCK|>! | $47B | |||
| IQVIA Holdings Inc
IQV
| LOCK|D^XB%xl | LOCK|BJX# | $43B | |||
| Waters Corp
WAT
| LOCK|J@xGgZd | LOCK|^s | $42B | |||
| IDEXX Laboratories Inc
IDXX
| LOCK|D?ng#Ch | LOCK|&W | $41B | |||
| Illumina Inc
ILMN
| LOCK|v&K!hD | LOCK|gJVl! | $40B | |||
| Mettler-Toledo International Inc
MTD
| LOCK|C$tst#d | LOCK|FXW<p | $30B | |||
| Quest Diagnostics Inc
DGX
| LOCK|Cj#q?< | LOCK|q>^Y% | $26B | |||
| Labcorp Holdings Inc
LH
| LOCK|djJr!hm@ | LOCK|T%yd | $25B |
United States